TEMPE, Ariz.--(BUSINESS WIRE)--Clinical Research Advantage (CRA), a company that provides clinical trial solutions for pharmaceutical sponsors and contract research organizations, has been named one of “Arizona’s Most Admired Companies.” The award was presented last night during the annual Most Admired Companies (MAC) event at the Ritz-Carlton in Phoenix, Ariz. CRA also received a Spotlight Award for “Fastest-Growing Company of the Year.”
The MAC awards are presented by AZ Business Magazine and BestCompaniesAZ. The companies are selected based on how they perform in the following areas: Workplace Culture, Leadership Excellence, Corporate and Social Responsibility, Customer Opinion, and Innovation.
"This is the most comprehensive and most prestigious corporate awards program in Arizona. It recognizes the contributions and impact these ‘Most Admired Companies’ bring to the state," said Denise Gredler, Founder and CEO of BestCompaniesAZ and cofounder of the MAC program.
Mark S. Hanley, CEO of Clinical Research Advantage, thanked the company’s employees for their hard work and continual dedication to excellence. “It is because of the great people who work at CRA that we have received this exceptional award,” he said.
All 40 of Arizona’s Most Admired Companies will be featured in the September/October issue of AZ Business Magazine.
About Clinical Research Advantage
Tempe, Arizona-based Clinical Research Advantage, Inc. (CRA) is the country’s largest wholly owned network of clinical trial sites. CRA works with pharmaceutical companies and contract research organizations to perform clinical trials for pharmaceuticals, vaccines and medical devices. The services provided by CRA allow trial sponsors to bring medical advancements to market quickly and efficiently. Founded in 1992, CRA acquired Radiant Research in 2012 and Comprehensive Clinical Development in 2013. Combined, the companies have successfully completed more than 11,000 clinical trials. For more information, please visit www.crastudies.com.
